How to take omeprazole and famotidine together
Pro Research Analysisby 
Searched over 200M research papers
How to Take Omeprazole and Famotidine Together
Introduction to Omeprazole and Famotidine
Omeprazole and famotidine are medications commonly used to treat conditions related to excess stomach acid, such as reflux esophagitis and peptic ulcers. Omeprazole is a proton pump inhibitor (PPI) that reduces stomach acid production, while famotidine is an H2-receptor antagonist that also decreases acid secretion but through a different mechanism.
Combined Use for Reflux Esophagitis
Clinical Efficacy
Several studies have demonstrated the effectiveness of combining omeprazole and famotidine for treating reflux esophagitis. Patients treated with both medications showed significant improvement in clinical symptoms and endoscopic lesions compared to those treated with either drug alone1 4 6. The combination therapy was found to be more effective, with a higher total effective rate and fewer adverse reactions, making it a safe and effective treatment option4 6.
Dosage and Administration
For optimal results, the recommended regimen involves taking 20 mg of omeprazole before breakfast and 20 mg of famotidine at bedtime1 6. This schedule ensures that acid suppression is maintained throughout the day and night, providing continuous relief from symptoms.
Comparative Studies in Dogs
Intragastric pH Control
Research on dogs has shown that omeprazole is more effective than famotidine in increasing intragastric pH levels, which is crucial for treating acid-related disorders2. Both omeprazole tablets and reformulated paste significantly increased the percentage of time that intragastric pH was above 3 and 4, compared to famotidine and placebo2. This suggests that while famotidine is effective, omeprazole provides superior acid suppression.
Helicobacter pylori Eradication
Enhanced Triple Therapy
In the context of Helicobacter pylori eradication, omeprazole has been shown to enhance the efficacy of triple therapy regimens. When combined with antibiotics, omeprazole significantly improved eradication rates compared to famotidine3. This highlights the importance of omeprazole in achieving higher success rates in treating H. pylori infections.
Gastrointestinal Adverse Events
Impact on Dogs with Cancer
A study on dogs with cancer treated with piroxicam found that the addition of omeprazole or famotidine did not reduce the frequency or severity of gastrointestinal adverse events (AEs)5. In fact, dogs receiving omeprazole experienced more frequent and severe GI AEs compared to those on placebo, suggesting that prophylactic use of these medications with NSAIDs may not be beneficial in this context5.
Conclusion
Combining omeprazole and famotidine can be highly effective for treating reflux esophagitis, providing superior symptom relief and endoscopic improvement compared to monotherapy. The recommended regimen involves taking omeprazole before breakfast and famotidine at bedtime. While omeprazole is generally more effective in increasing intragastric pH and enhancing H. pylori eradication, caution is advised when using these medications prophylactically with NSAIDs due to potential gastrointestinal adverse events.
Sources and full results
Most relevant research papers on this topic
Analysis of reflux esophagitis cured by omeprazole and famotidine
Omeprazole combined with famotidine effectively treats reflux esophagitis, improving clinical symptoms and endoscopic lesions compared to other treatment groups.
Observational StudyEfficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs.
Oral omeprazole tablet and reformulated paste provide superior gastric acid suppression to famotidine, making them more effective for treating acid-related disorders in dogs.
RCT
Animal Study
Highly CitedOmeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.
Omeprazole combined with triple therapy effectively enhances Helicobacter pylori eradication to over 97%, regardless of whether the bacteria is metronidazole sensitive or resistant.
RCT
Large Human TrialHighly CitedAnalysis on omeprazole combined with famotidine in treatment of reflux esophagitis
Omeprazole combined with famotidine effectively treats reflux esophagitis, with a higher effective rate (97.14%) than control group (65.71%), making it safe and effective for clinical application.
RCTA prospective, randomized, placebo-controlled, double-blinded clinical trial comparing the incidence and severity of gastrointestinal adverse events in dogs with cancer treated with piroxicam alone or in combination with omeprazole or famotidine.
Omeprazole did not reduce gastrointestinal adverse events and may have increased them in dogs with cancer treated with single agent piroxicam, suggesting it should not be used as a prophylaxis with NSAIDs.
RCTAnimal StudyClinical Analysis on the Effect of Omeprazole Combined with Famotidine on the Treatment of Reflux Esophagitis
Omeprazole combined with famotidine effectively restrains stomach acid secretion, providing reliable curative effect on reflux esophagitis.
RCTThe comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH
In Helicobacter pylori-negative healthy male subjects, famotidine 20 mg increases intragastric pH more rapidly than omeprazole 20 mg, potentially benefiting patients with acid-related diseases.
RCTCan famotidine and omeprazole be combined on a once-daily basis?
Famotidine and omeprazole can be combined on a once-daily basis for rapid acid control and long-lasting antisecretory effect.
Non-RCTEfficacy of omeprazole versus high-dose famotidine for prevention of exercise-induced gastritis in racing Alaskan sled dogs.
Omeprazole is more effective than high-dose famotidine in preventing exercise-induced gastritis in dogs running 300 miles.
RCTAnimal StudyInfluence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study.
Concomitant use of low-dose omeprazole does not significantly attenuate the antiplatelet effects of clopidogrel in patients with acute coronary syndromes, especially in those with STEMI.
RCT